Back to products
SAFE SERIES Blood Collection Needles Amaris Medical
SAFE SERIES Blood Collection Needles Original price was: $88.46.Current price is: $84.04.

Anti-Streptol Olysin O Titer (ASOT)

Original price was: $24.23.Current price is: $23.02.

WhatsApp Order
Anti-Streptol Olysin O Titer (ASOT) is a quantitative or semi-quantitative serological test (latex agglutination, turbidimetry, nephelometry, or ELISA) for detecting antibodies against streptolysin O, an exotoxin produced by Group A Streptococcus. Elevated or rising titers indicate recent streptococcal infection and are essential for diagnosing post-streptococcal sequelae including acute rheumatic fever (Jones criteria) and post-streptococcal glomerulonephritis. The test requires serum samples; acute and convalescent (2-4 weeks apart) with fourfold rise confirms recent infection. Reference range typically <200-250 Todd units/mL (adults), varies by age and population. Primary clinical applications include diagnosis of Group A streptococcal infections, acute rheumatic fever evaluation, post-streptococcal glomerulonephritis diagnosis, differentiation of acute vs. past infection, evaluation of unexplained arthritis or carditis, pediatric inflammatory conditions (PANDAS), and monitoring disease activity in rheumatic fever. Critical safety precautions include proper timing of acute and convalescent samples, awareness of false negatives/positives, clinical correlation for diagnosis, and standard biohazard precautions. Essential test for rheumatology, nephrology, cardiology, and infectious disease practice.
Description

Anti-Streptol Olysin O Titer (ASOT)

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Diagnosis of Group A Streptococcal Infections:
  • Primary Use: ASOT measures antibodies produced by the immune system in response to streptolysin O, a toxin released by Group A Streptococcus bacteria. Elevated levels indicate that the body has mounted an immune response to a recent or past infection with this bacterium, which causes illnesses such as strep throat, scarlet fever, and skin infections.
  • How it helps: Confirming a recent strep infection helps doctors decide whether antibiotics are needed and provides reassurance that symptoms like sore throat or rash have a clear, treatable cause.
2. Diagnosis of Acute Rheumatic Fever:
  • Primary Use: ASOT is a standard laboratory test used as part of the Jones criteria to diagnose acute rheumatic fever, an inflammatory condition that can develop after an untreated strep infection. It affects the heart, joints, skin, and brain. Rising or elevated antibody levels support this diagnosis in patients with symptoms like chest pain, swollen joints, or involuntary movements.
  • How it helps: Early diagnosis allows doctors to start treatment quickly to reduce inflammation, manage symptoms, and prevent long-term damage to the heart valves.
3. Diagnosis of Post-Streptococcal Glomerulonephritis:
  • Primary Use: Elevated ASOT helps confirm post-streptococcal glomerulonephritis, a kidney condition that can appear 1 to 3 weeks after a strep infection. It occurs when immune complexes deposited in the kidneys cause inflammation, leading to symptoms like blood in the urine, swelling, and high blood pressure.
  • How it helps: Identifying the link between a recent strep infection and kidney inflammation helps doctors provide targeted care, monitor kidney function, and prevent complications.
4. Differentiation of Acute vs. Past Infection:
  • Primary Use: Serial ASOT measurements taken a few weeks apart can show whether antibody levels are rising. A significant increase (typically fourfold or greater) indicates a recent or current infection. Stable but elevated levels suggest a past infection that is no longer active.
  • How it helps: This distinction guides treatment decisions—active infections may require intervention, while past infections do not, preventing unnecessary use of antibiotics or other therapies.
5. Evaluation of Unexplained Arthritis or Carditis:
  • Primary Use: ASOT is used in the workup of patients with unexplained joint pain or inflammation, or heart inflammation, where a preceding strep infection is suspected but not confirmed.
  • How it helps: Establishing a link to a prior strep infection helps doctors diagnose conditions like post-streptococcal reactive arthritis or rheumatic heart disease, leading to appropriate rheumatology or cardiology care.
6. Pediatric Inflammatory Conditions:
  • Primary Use: In children, ASOT may be used to evaluate conditions such as Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), where symptoms like obsessive-compulsive behavior or tics appear after a strep infection.
  • How it helps: Confirming a temporal relationship with strep infection helps guide management, which may include antibiotics, immunotherapy, or behavioral therapy, and provides families with a clearer understanding of the condition.
7. Monitoring Disease Activity in Rheumatic Fever:
  • Primary Use: Serial ASOT measurements can be used to monitor disease activity in patients with acute rheumatic fever, although other markers like ESR and CRP are more commonly used for this purpose.
  • How it helps: Tracking antibody levels over time provides additional information about disease progression and response to treatment, contributing to a more complete picture of patient health.

SECONDARY & SUPPORTIVE USES

1. Epidemiological Studies: Used in research to understand how common strep infections are in different communities and regions, helping public health officials plan prevention strategies.
2. Outbreak Investigation: Helps public health teams confirm strep as the cause of outbreaks in schools, nursing homes, or other closed communities, enabling timely control measures.
3. Rheumatic Heart Disease Screening: In parts of the world where rheumatic heart disease is common, ASOT may be used in screening programs to identify individuals with a history of strep infection who may be at risk.
4. Preoperative Assessment in Cardiac Surgery: Occasionally ordered for patients with a history of rheumatic heart disease who are scheduled for valve surgery, to check for signs of active infection that could affect the procedure.
5. Research on Post-Streptococcal Sequelae: Used in studies exploring why some people develop complications like rheumatic fever or kidney disease after a strep infection, helping researchers develop better prevention and treatment strategies.
6. Differential Diagnosis of Glomerulonephritis: Helps doctors distinguish post-streptococcal glomerulonephritis from other types of kidney disease, such as lupus nephritis or IgA nephropathy, ensuring patients receive the correct treatment.
7. Autoimmune Disorder Workup: Sometimes included in the evaluation of suspected autoimmune diseases where an infection may have triggered the condition, providing clues about the underlying cause.
KEY PRODUCT FEATURES

1. BASIC IDENTIFICATION ATTRIBUTES

  • Test Type: Quantitative or semi-quantitative serological test for antibodies against streptolysin O.
  • Common Names: ASO, ASOT, Anti-Streptolysin O Titer, Streptolysin O Antibodies.
  • Sample Type: Serum (venous blood).
  • Methodologies:
    • Latex Agglutination: Semi-quantitative, rapid screening.
    • Turbidimetry/Nephelometry: Automated quantitative immunoassay.
    • ELISA: Enzyme-linked immunosorbent assay for quantitative measurement.
    • Microtitration: Traditional tube dilution method.
  • Reporting Units: Todd units/mL or IU/mL.
  • Reference Range: Varies by age, population, and methodology; typically <200-250 Todd units/mL in adults, <150-200 in children.

2. TECHNICAL & PERFORMANCE PROPERTIES

  • Sensitivity: 85-95% for detecting recent streptococcal infection when both acute and convalescent samples tested.
  • Specificity: Moderate (60-80%) due to background prevalence of streptococcal infections in the population.
  • Titer Rise: Fourfold or greater increase between acute and convalescent sera (2-4 weeks apart) indicates recent infection.
  • Time to Peak: Antibodies peak 3-6 weeks after infection, then gradually decline over months to years.
  • Cross-Reactivity: May cross-react with other streptococcal antibodies; false positives possible in liver disease, rheumatoid factor positive conditions.
  • Method Comparison: Automated methods correlate well with traditional tube dilution; latex agglutination provides rapid screening but less precise quantitation.

3. PHYSICAL & OPERATIONAL PROPERTIES

  • Kit Components (Latex Method):
    • Latex Reagent: Polystyrene latex particles coated with streptolysin O.
    • Positive Control: Serum with known ASO titer.
    • Negative Control: Non-reactive serum.
    • Dilution Buffer: For sample preparation.
    • Reaction Cards: Black glass or plastic cards for agglutination reading.
    • Mixing Sticks: Disposable sticks for sample-reagent mixing.
  • Kit Components (Turbidimetric/Nephelometric):
    • Reagent 1: Buffer/diluent.
    • Reagent 2: Latex particles coated with streptolysin O.
    • Calibrators: Set of known ASO concentrations.
    • Controls: Commercial controls at various levels.
  • Packaging Sizes: 50-200 tests per kit depending on methodology.
  • Storage Requirements: 2-8°C; do not freeze.
  • Shelf Life: 12-24 months depending on manufacturer.

4. SAFETY & COMPLIANCE ATTRIBUTES

  • Regulatory Status: Class II medical device requiring FDA 510(k) clearance; CE marked for IVD use.
  • Quality Control: Must run positive and negative controls with each batch; calibration curves for quantitative methods.
  • Biohazard Precautions: All patient samples potentially infectious for HIV, hepatitis B/C, and other bloodborne pathogens.
  • Chemical Safety: Reagents contain preservatives (sodium azide); avoid contact with eyes and skin.
  • Disposal: Used test materials disposed as biohazardous waste.
  • Reporting: Results reported to ordering physician; titers above reference range indicate recent infection.

5. STORAGE & HANDLING ATTRIBUTES

  • Storage Temperature: 2-8°C; do not freeze; protect from light.
  • Sample Handling: Serum stable 7 days at 2-8°C; longer storage requires freezing at -20°C.
  • Reagent Preparation: Bring reagents to room temperature before use; mix gently; avoid foam.
  • Expiration: Never use reagents beyond expiration date; performance compromised.
  • Quality Control: Run controls with each batch; document results per laboratory protocol.
  • Disposal: Dispose of contaminated materials in biohazard containers.

6. LABORATORY & CLINICAL APPLICATIONS

  • Primary Application: Detection and quantitation of anti-streptolysin O antibodies for diagnosis of recent Group A streptococcal infection and its sequelae (rheumatic fever, post-streptococcal glomerulonephritis).
  • Testing Indications:
    • Suspected acute rheumatic fever (Jones criteria).
    • Acute glomerulonephritis (especially in children).
    • Unexplained arthritis or carditis.
    • History of recent pharyngitis with current inflammatory symptoms.
    • Evaluation of chorea (Sydenham's chorea).
  • Interpretation:
    • Elevated Single Titer: Indicates recent infection but does not differentiate acute from past infection.
    • Rising Titer (4-fold): Confirms recent or current infection.
    • Stable Elevated Titer: May indicate past infection, carrier state, or persistent elevation.
    • Negative Titer: Does not rule out streptococcal infection if tested too early or late.
  • Limitations: Cannot distinguish between different streptococcal infections; elevated in only 80-85% of post-streptococcal sequelae; background population prevalence affects specificity.
SAFETY HANDLING PRECAUTIONS

1. SAFETY PRECAUTIONS

  • Biological Hazard: All serum samples potentially infectious; wear gloves and appropriate PPE.
  • Hand Hygiene: Wash hands thoroughly after handling specimens and reagents.
  • Quality Control: Always run controls with each batch; invalid if controls fail.
  • Timing of Testing: Acute sample should be collected at presentation; convalescent sample 2-4 weeks later.
  • Clinical Correlation: ASOT alone is not diagnostic; must be interpreted with clinical presentation and other laboratory findings.
  • Pediatric Interpretation: Reference ranges vary by age; higher titers more common in school-aged children.
  • False Negatives: May occur if tested too early (before antibody rise) or too late (after decline).
  • False Positives: Can occur in liver disease, rheumatoid factor, or other conditions.

2. FIRST AID MEASURES

  • Needlestick/Sharps Injury: If injury occurs during blood collection, wash area vigorously with soap and water; report immediately; follow institutional post-exposure prophylaxis protocol.
  • Blood Spill: Contain with absorbent material; disinfect area with 10% bleach solution; dispose as biohazard waste.
  • Reagent Contact (Eyes): Flush eyes with copious water for 15 minutes; seek medical attention.
  • Reagent Ingestion: Contact poison control center; do not induce vomiting unless instructed.

3. FIRE FIGHTING MEASURES

  • Flammability: Liquid reagents contain preservatives; plastic components combustible.
  • Extinguishing Media: Use water, foam, COâ‚‚, or dry chemical as appropriate.
  • Sodium Azide Hazard: Reagents may contain sodium azide; may react with lead/copper plumbing to form explosive azides; flush with copious water when disposing.